Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Latest filing published 24 Mar 2026 for Neuronetics, Inc., €19k. Read the official filing
Filing timeline
BuySaleWilliam Andrew Macan
Insider track record
Disclosed buys
0
Disclosed sells
25
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William Andrew Macan: trading record in brief
All filings by William Andrew Macan on record concern Neuronetics, Inc. Between 8 July 2021 and 19 March 2026, the trades on record add up to 32 filings.
The open-market record consists of 25 sales worth €684k, with no purchase. Outside the open market, there are 7 share grants. So far in 2026, the count stands at no purchases and 5 sales.
The latest filing, published on 24 March 2026, reports an open-market sale of €19k in Neuronetics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Andrew Macan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
16,005 shares@ US$1.342.9% of flowCommon StockSEC:0001193125-26-122290:0
33,750 shares0Common StockSEC:0001193125-26-114114:0
609 shares@ US$1.340.1% of flowCommon StockSEC:0001193125-26-096629:0
3,427 shares@ US$1.350.6% of flowCommon StockSEC:0001193125-26-082878:0
210,000 shares0Common StockSEC:0001193125-26-071773:0
14,120 shares@ US$1.652.9% of flowCommon StockSEC:0001193125-26-057538:0
3,485 shares@ US$1.550.7% of flowCommon StockSEC:0001193125-26-048851:0
164,361 shares0Common StockSEC:0001193125-25-338393:0
377 shares@ US$4.480.2% of flowCommon StockSEC:0000950170-25-034868:0
157,500 shares0Common StockSEC:0000950170-25-028006:0
18,965 shares@ US$4.1110.4% of flowCommon StockSEC:0000950170-25-022433:0
12,175 shares@ US$3.836.3% of flowCommon StockSEC:0000950170-25-021391:0
1,970 shares@ US$3.280.9% of flowCommon StockSEC:0000950170-25-018969:0
1,541 shares@ US$0.820.2% of flowCommon StockSEC:0000950170-24-114102:0
22,377 shares@ US$3.169.1% of flowCommon StockSEC:0000950170-24-024006:0
15,621 shares@ US$3.386.9% of flowCommon StockSEC:0000950170-24-016536:0
90,000 shares0Common StockSEC:0001209191-24-002958:0
11,664 shares@ US$2.243.3% of flowCommon StockSEC:0001062993-23-023059:0
1,469 shares@ US$1.1550.2% of flowCommon StockSEC:0001062993-23-019211:0
2,645 shares@ US$2.130.7% of flowCommon StockSEC:0001062993-23-014852:0
12,692 shares@ US$4.597.6% of flowCommon StockSEC:0001062993-23-006417:0
11,974 shares@ US$5.909.2% of flowCommon StockSEC:0001062993-23-004066:0
5,162 shares@ US$5.994.0% of flowCommon StockSEC:0001209191-23-008117:0
16,046 shares@ US$5.9612.3% of flowCommon StockSEC:0001062993-23-001322:0
1,547 shares@ US$2.930.6% of flowCommon StockSEC:0001062993-22-020704:0
25 of 32 declarations
